텔콘RF제약

200230KOSDAQ

56.5 / 100

Reference Date: 2026-09-08

Financial Score24.0 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Telcon RF Pharmaceuticals primarily manufactures connectors and cable assemblies for wireless communication equipment, expanding into optical solutions and 5G FTTA (Fiber-To-The-Antenna) technology to strengthen its global market position. In the pharmaceutical and biotech sector, the company produces various dosage forms using KGMP-certified facilities and invests in new drug development.

Number of Employees

133people

Average Salary

55.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.19Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-11.91Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

1.46Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲505.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.4% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (79%)

Current 2,230Won52-week high 2,72052-week low 360

1-month return3.0Point

1m -0.22% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14